The global Targeted Radiotherapy Drug market size was valued at USD 6075.9 million in 2022 and is forecast to a readjusted size of USD 8868.3 million by 2029 with a CAGR of 5.6% during review period.
Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.
Report includes an overview of the development of the Targeted Radiotherapy Drug industry chain, the market status of General Hospital (Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs), Specialty Hospital (Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Targeted Radiotherapy Drug.
Regionally, the report analyzes the Targeted Radiotherapy Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Radiotherapy Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Radiotherapy Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Radiotherapy Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Radiotherapy Drug market.
Regional Analysis: The report involves examining the Targeted Radiotherapy Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Radiotherapy Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Radiotherapy Drug:
Company Analysis: Report covers individual Targeted Radiotherapy Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Targeted Radiotherapy Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (General Hospital, Specialty Hospital).
Technology Analysis: Report covers specific technologies relevant to Targeted Radiotherapy Drug. It assesses the current state, advancements, and potential future developments in Targeted Radiotherapy Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Radiotherapy Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Novartis
Bayer
Endocyte
Progenics Pharmaceuticals
Jubilant Radiopharma
Curium
Fermi Energia
Nucleus RadioPharma
Radioactive Iodine Therapeutic Drugs
Radioactive Antibody Therapeutic Drugs
Others
General Hospital
Specialty Hospital
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Targeted Radiotherapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Radiotherapy Drug, with revenue, gross margin and global market share of Targeted Radiotherapy Drug from 2018 to 2023.
Chapter 3, the Targeted Radiotherapy Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Targeted Radiotherapy Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Radiotherapy Drug.
Chapter 13, to describe Targeted Radiotherapy Drug research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Targeted Radiotherapy Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Targeted Radiotherapy Drug by Type
1.3.1 Overview: Global Targeted Radiotherapy Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Targeted Radiotherapy Drug Consumption Value Market Share by Type in 2022
1.3.3 Radioactive Iodine Therapeutic Drugs
1.3.4 Radioactive Antibody Therapeutic Drugs
1.3.5 Others
1.4 Global Targeted Radiotherapy Drug Market by Application
1.4.1 Overview: Global Targeted Radiotherapy Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 General Hospital
1.4.3 Specialty Hospital
1.5 Global Targeted Radiotherapy Drug Market Size & Forecast
1.6 Global Targeted Radiotherapy Drug Market Size and Forecast by Region
1.6.1 Global Targeted Radiotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Targeted Radiotherapy Drug Market Size by Region, (2018-2029)
1.6.3 North America Targeted Radiotherapy Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Targeted Radiotherapy Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Targeted Radiotherapy Drug Market Size and Prospect (2018-2029)
1.6.6 South America Targeted Radiotherapy Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Targeted Radiotherapy Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Targeted Radiotherapy Drug Product and Solutions
2.1.4 Novartis Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Targeted Radiotherapy Drug Product and Solutions
2.2.4 Bayer Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments and Future Plans
2.3 Endocyte
2.3.1 Endocyte Details
2.3.2 Endocyte Major Business
2.3.3 Endocyte Targeted Radiotherapy Drug Product and Solutions
2.3.4 Endocyte Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Endocyte Recent Developments and Future Plans
2.4 Progenics Pharmaceuticals
2.4.1 Progenics Pharmaceuticals Details
2.4.2 Progenics Pharmaceuticals Major Business
2.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Product and Solutions
2.4.4 Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Progenics Pharmaceuticals Recent Developments and Future Plans
2.5 Jubilant Radiopharma
2.5.1 Jubilant Radiopharma Details
2.5.2 Jubilant Radiopharma Major Business
2.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Product and Solutions
2.5.4 Jubilant Radiopharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jubilant Radiopharma Recent Developments and Future Plans
2.6 Curium
2.6.1 Curium Details
2.6.2 Curium Major Business
2.6.3 Curium Targeted Radiotherapy Drug Product and Solutions
2.6.4 Curium Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Curium Recent Developments and Future Plans
2.7 Fermi Energia
2.7.1 Fermi Energia Details
2.7.2 Fermi Energia Major Business
2.7.3 Fermi Energia Targeted Radiotherapy Drug Product and Solutions
2.7.4 Fermi Energia Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fermi Energia Recent Developments and Future Plans
2.8 Nucleus RadioPharma
2.8.1 Nucleus RadioPharma Details
2.8.2 Nucleus RadioPharma Major Business
2.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Product and Solutions
2.8.4 Nucleus RadioPharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nucleus RadioPharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted Radiotherapy Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Targeted Radiotherapy Drug by Company Revenue
3.2.2 Top 3 Targeted Radiotherapy Drug Players Market Share in 2022
3.2.3 Top 6 Targeted Radiotherapy Drug Players Market Share in 2022
3.3 Targeted Radiotherapy Drug Market: Overall Company Footprint Analysis
3.3.1 Targeted Radiotherapy Drug Market: Region Footprint
3.3.2 Targeted Radiotherapy Drug Market: Company Product Type Footprint
3.3.3 Targeted Radiotherapy Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Targeted Radiotherapy Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Targeted Radiotherapy Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Targeted Radiotherapy Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America Targeted Radiotherapy Drug Consumption Value by Type (2018-2029)
6.2 North America Targeted Radiotherapy Drug Consumption Value by Application (2018-2029)
6.3 North America Targeted Radiotherapy Drug Market Size by Country
6.3.1 North America Targeted Radiotherapy Drug Consumption Value by Country (2018-2029)
6.3.2 United States Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Targeted Radiotherapy Drug Consumption Value by Type (2018-2029)
7.2 Europe Targeted Radiotherapy Drug Consumption Value by Application (2018-2029)
7.3 Europe Targeted Radiotherapy Drug Market Size by Country
7.3.1 Europe Targeted Radiotherapy Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
7.3.3 France Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Targeted Radiotherapy Drug Market Size by Region
8.3.1 Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Region (2018-2029)
8.3.2 China Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8.3.5 India Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America Targeted Radiotherapy Drug Consumption Value by Type (2018-2029)
9.2 South America Targeted Radiotherapy Drug Consumption Value by Application (2018-2029)
9.3 South America Targeted Radiotherapy Drug Market Size by Country
9.3.1 South America Targeted Radiotherapy Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Targeted Radiotherapy Drug Market Size by Country
10.3.1 Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Targeted Radiotherapy Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Targeted Radiotherapy Drug Market Drivers
11.2 Targeted Radiotherapy Drug Market Restraints
11.3 Targeted Radiotherapy Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Targeted Radiotherapy Drug Industry Chain
12.2 Targeted Radiotherapy Drug Upstream Analysis
12.3 Targeted Radiotherapy Drug Midstream Analysis
12.4 Targeted Radiotherapy Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Targeted Radiotherapy Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Targeted Radiotherapy Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Targeted Radiotherapy Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Targeted Radiotherapy Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis Targeted Radiotherapy Drug Product and Solutions
Table 8. Novartis Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Bayer Company Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Targeted Radiotherapy Drug Product and Solutions
Table 13. Bayer Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bayer Recent Developments and Future Plans
Table 15. Endocyte Company Information, Head Office, and Major Competitors
Table 16. Endocyte Major Business
Table 17. Endocyte Targeted Radiotherapy Drug Product and Solutions
Table 18. Endocyte Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Endocyte Recent Developments and Future Plans
Table 20. Progenics Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Progenics Pharmaceuticals Major Business
Table 22. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product and Solutions
Table 23. Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Progenics Pharmaceuticals Recent Developments and Future Plans
Table 25. Jubilant Radiopharma Company Information, Head Office, and Major Competitors
Table 26. Jubilant Radiopharma Major Business
Table 27. Jubilant Radiopharma Targeted Radiotherapy Drug Product and Solutions
Table 28. Jubilant Radiopharma Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Jubilant Radiopharma Recent Developments and Future Plans
Table 30. Curium Company Information, Head Office, and Major Competitors
Table 31. Curium Major Business
Table 32. Curium Targeted Radiotherapy Drug Product and Solutions
Table 33. Curium Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Curium Recent Developments and Future Plans
Table 35. Fermi Energia Company Information, Head Office, and Major Competitors
Table 36. Fermi Energia Major Business
Table 37. Fermi Energia Targeted Radiotherapy Drug Product and Solutions
Table 38. Fermi Energia Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Fermi Energia Recent Developments and Future Plans
Table 40. Nucleus RadioPharma Company Information, Head Office, and Major Competitors
Table 41. Nucleus RadioPharma Major Business
Table 42. Nucleus RadioPharma Targeted Radiotherapy Drug Product and Solutions
Table 43. Nucleus RadioPharma Targeted Radiotherapy Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Nucleus RadioPharma Recent Developments and Future Plans
Table 45. Global Targeted Radiotherapy Drug Revenue (USD Million) by Players (2018-2023)
Table 46. Global Targeted Radiotherapy Drug Revenue Share by Players (2018-2023)
Table 47. Breakdown of Targeted Radiotherapy Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Targeted Radiotherapy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Targeted Radiotherapy Drug Players
Table 50. Targeted Radiotherapy Drug Market: Company Product Type Footprint
Table 51. Targeted Radiotherapy Drug Market: Company Product Application Footprint
Table 52. Targeted Radiotherapy Drug New Market Entrants and Barriers to Market Entry
Table 53. Targeted Radiotherapy Drug Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Targeted Radiotherapy Drug Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Targeted Radiotherapy Drug Consumption Value Share by Type (2018-2023)
Table 56. Global Targeted Radiotherapy Drug Consumption Value Forecast by Type (2024-2029)
Table 57. Global Targeted Radiotherapy Drug Consumption Value by Application (2018-2023)
Table 58. Global Targeted Radiotherapy Drug Consumption Value Forecast by Application (2024-2029)
Table 59. North America Targeted Radiotherapy Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Targeted Radiotherapy Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Targeted Radiotherapy Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Targeted Radiotherapy Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Targeted Radiotherapy Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Targeted Radiotherapy Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Targeted Radiotherapy Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Targeted Radiotherapy Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Targeted Radiotherapy Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Targeted Radiotherapy Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Targeted Radiotherapy Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Targeted Radiotherapy Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Targeted Radiotherapy Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Targeted Radiotherapy Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Targeted Radiotherapy Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Targeted Radiotherapy Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Targeted Radiotherapy Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Targeted Radiotherapy Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Targeted Radiotherapy Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Targeted Radiotherapy Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Targeted Radiotherapy Drug Raw Material
Table 90. Key Suppliers of Targeted Radiotherapy Drug Raw Materials
List of Figures
Figure 1. Targeted Radiotherapy Drug Picture
Figure 2. Global Targeted Radiotherapy Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Targeted Radiotherapy Drug Consumption Value Market Share by Type in 2022
Figure 4. Radioactive Iodine Therapeutic Drugs
Figure 5. Radioactive Antibody Therapeutic Drugs
Figure 6. Others
Figure 7. Global Targeted Radiotherapy Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Targeted Radiotherapy Drug Consumption Value Market Share by Application in 2022
Figure 9. General Hospital Picture
Figure 10. Specialty Hospital Picture
Figure 11. Global Targeted Radiotherapy Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Targeted Radiotherapy Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Targeted Radiotherapy Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Targeted Radiotherapy Drug Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Targeted Radiotherapy Drug Consumption Value Market Share by Region in 2022
Figure 16. North America Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Targeted Radiotherapy Drug Revenue Share by Players in 2022
Figure 22. Targeted Radiotherapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Targeted Radiotherapy Drug Market Share in 2022
Figure 24. Global Top 6 Players Targeted Radiotherapy Drug Market Share in 2022
Figure 25. Global Targeted Radiotherapy Drug Consumption Value Share by Type (2018-2023)
Figure 26. Global Targeted Radiotherapy Drug Market Share Forecast by Type (2024-2029)
Figure 27. Global Targeted Radiotherapy Drug Consumption Value Share by Application (2018-2023)
Figure 28. Global Targeted Radiotherapy Drug Market Share Forecast by Application (2024-2029)
Figure 29. North America Targeted Radiotherapy Drug Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Targeted Radiotherapy Drug Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Targeted Radiotherapy Drug Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Targeted Radiotherapy Drug Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 39. France Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Targeted Radiotherapy Drug Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Targeted Radiotherapy Drug Consumption Value Market Share by Region (2018-2029)
Figure 46. China Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. India Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Targeted Radiotherapy Drug Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Targeted Radiotherapy Drug Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Targeted Radiotherapy Drug Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Targeted Radiotherapy Drug Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Targeted Radiotherapy Drug Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. Targeted Radiotherapy Drug Market Drivers
Figure 64. Targeted Radiotherapy Drug Market Restraints
Figure 65. Targeted Radiotherapy Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Targeted Radiotherapy Drug in 2022
Figure 68. Manufacturing Process Analysis of Targeted Radiotherapy Drug
Figure 69. Targeted Radiotherapy Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
